DDRT

DanDrit Biotech USA, Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 6/16/2017
Contact Info
  • Fruebjergvej 3 Box 62
  • Copenhagen 2100
  • Denmark

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0001527728
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2011
Employees 3 a/o Dec 23, 2016
Company Officers/Contacts
Eric Leire CEO
Company Directors
Torben Bjorn Christensen
Eric Leire
Rene Sindlev
Service Providers
Accounting/Auditing Firm
Gregory & Associates, LLC
19 120th Street
Ocean City, MD, 21842
United States
 
Securities Counsel
K&L Gates LLP OTCQX Sponsor
200 S. Biscayne Blvd
Suite 3900
Miami, FL, 33131
United States
 
Investor Relations Firm
Wolfe Axelrod Weinberger Associates, LLC
One Grand Central Place
60 East 42nd Street
Suite 2534
New York, NY, 10165
United States
 
DDRT Security Details
Share Structure
Market Value1 $31,918,820 a/o Jun 27, 2017
Authorized Shares 100,000,000 a/o Sep 28, 2016
Outstanding Shares 16,453,000 a/o May 15, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 7,402,528 a/o Sep 28, 2016
Par Value Not Available
Shareholders
Shareholders of Record 75 a/o Sep 28, 2016
Short Selling Data
Short Interest 534 (747.62%)
Jun 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security